The Monks Investment Trust PLC

The Monks Investment Trust PLC

MNKIF
The Monks Investment Trust PLCUS flagOther OTC
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
The Monks Investment Trust PLC (Ticker: MNKIF) is a UK-listed investment trust focused on long-term capital growth through a global portfolio of high-quality growth stocks. It invests primarily in equities across diverse sectors including technology, healthcare, consumer discretionary, and industrials; key holdings typically feature innovative companies with strong competitive advantages and scalable business models. The trust offers ordinary shares traded on the London Stock Exchange, with a focus on companies demonstrating sustainable earnings growth potential, and employs a bottom-up stock selection process emphasizing global opportunities outside the UK. Founded in 1929 and headquartered in Edinburgh, Scotland, the trust is managed by Baillie Gifford & Co., a leading independent investment management firm. It operates with a global geographic footprint, with investments spanning North America, Europe, Asia-Pacific, and emerging markets; target investors include retail and institutional clients seeking exposure to growth-oriented equities. The trust maintains a policy of gearing to enhance returns and distributes dividends semi-annually from income reserves. Recent developments include a strategic shift in 2022 towards a more concentrated portfolio of 40-60 high-conviction holdings to amplify long-term performance potential, alongside continued emphasis on technology and healthcare sectors amid market volatility. In 2024, the trust announced enhancements to its ESG integration framework, incorporating climate risk assessments and biodiversity metrics into investment decisions without compromising growth objectives. Baillie Gifford also expanded its manager team in late 2023 with the addition of specialist analysts to bolster coverage of AI-driven and biotech subsectors.